- How Stock Investors Can Play Holiday Travel
- 3 Growth Opportunities in Tech: Analyst
- Prep Your Portfolio for Next Week: Stock Pickers
- Global Growth Good for Portfolio: Stock Picker
- Expect Tech Sector to Rise in Q4: Strategist
- Expect a 5-10% Market Pullback: Stock Picker
- 3 Stock Picks for This Volatile Environment: Portfolio Manager
- 3 Financial Stocks May Lead Final Rally: Market Researcher
- Gold's 'Money' Value is $4,000 to $11,000: Market Strategist
- Commercial Real Estate Bottom Near: Market Pro
MOST SHARED
- Wall Street Finds Profits by Reducing Mortgages
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- Dems Snare 60 Votes to Move Ahead on Health Care
- Senate Democrats at Odds Over Health Care Bill
- South Korea Think-Tank sees 2010 GDP at 8-Year High
- Reliance Reportedly Offering $12 Billion for Lyondell
- CNBC VIDEO: Warren Buffett & Bill Gates 'Walk & Talk' at Columbia University
- U.S. Stocks Slip, Dollar Rises
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
- MBS Program Should be Extended: Fed's Bullard
- Wall Street Finds Profits by Reducing Mortgages
- Microsoft, News Corp Weigh Online News Pact
- Warren Buffett, Bill Gates 'Walk & Talk' At Columbia
- Senate Democrats at Odds Over Health Care Bill
- What if a Recovery Is All in Your Head?
- Thanksgiving Week Stuffed With Economic News
- 10 Tips to Get Out of Debt
- This Season: Everybody's A Scrooge
RSS FEED
CNBC Stock Blog
Text Size 
Options action on Watson Phamaceuticals [WPI
Loading...
()
]indicates that traders think it might be a takeover target, according to one options experts.
"This is an interesting stock because it has landed in the cross-hairs of very eager call buyers previously on speculation that it might make an attractive takeover target," said Rebecca Darts of Interactive Brokers said Thursday morning on CNBC's "Squawk Box." "Most recently, we saw this back on July 21, in the wake of Teva's [TEVJF
Loading...
()
] takeover of Barr Pharmaceuticals [BRL
Loading...
()
], but yesterday, with shares in Watson trading flat, we saw call volume hit a 52-week high, sending overall volume to about 14 times the normal volume."
Calls, which the buyer an option to buy a stock at a particular strike price in the future, are very active, she indicated.
"During the past month, call open interest -- which is the number of open call position contracts to buy Watson stock -- has increased 77 percent, so that tells us there's a rising litany of bulls on Watson Pharmaceuticals, and this is going to be an interesting stock to watch, even though there's not a specific rumor right now."
Data is a real-time snapshot *Data is delayed at least 15 minutes